Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-924-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Based on a weight of evidence-approach using two read across-studies, the acute oral LD50 of the test substance was determined to be >2000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- ANALOGUE APPROACH JUSTIFICATION
Please refer to the attached read across justification in section 13. - Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- only one sex tested, limitations in study reporting
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 10 490 mg/kg bw
- 95% CL:
- > 9 833 - <= 11 191
- Interpretation of results:
- not classified
- Conclusions:
- The median lethal dose of the test item (LD50) was 10490 mg per kg body weight. Based on the result of this study the test item is not subject for labelling and classification requirements according to regulatory requirements.
- Executive summary:
Based on results of the study conducted equivalent to OECD Guideline No 401 in rats, the median lethal dose of the read across item (CAS 39322-78-6) was 10490 mg per kg body weight.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- ANALOGUE APPROACH JUSTIFICATION
Please refer to the attached read-across justification in section 13. - Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Control animals:
- no
- Key result
- Sex:
- female
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The oral LD50 females was determined to be > 2000 mg/kg bw.
- Executive summary:
The acute oral toxicity in rats was determined according to the method recommended in the OECD Guideline No. 420, "Acute Oral Toxicity - Fixed Dose Procedure", December 2001, and the commission directive 2004/73/EC "B.1 bis Acute Oral Toxicity: Fixed Dose Procedure", April 2004. The study was initiated with a sighting study, in which one female rat was given the read across-substance (CAS 68987 -29 -1) in a 2000 mg/kg bw dose. Slight signs of toxicosis (piloerection) were observed in this rat. Based on the results from the sighting study, the main study was carried out with four more female animals each given a dose of 2000 mg/kg bw. All animals in the main study survived the treatment, weight gain was normal and apart from piloerection no other clinical signs were observed. The gross necropsy of the animals revealed no pathological abnormalities. The oral LD50 females was determined to be > 2000 mg/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2007-01-17 to 2007-02-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Specific details on test material used for the study:
- Name of test material: Silastol H 200
- CAS No.: 68987-29-1 - Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland GmbH, 0-97633 Sulzfeld
- Weight at study initiation: 164 g - 176 g.
- Fasting period before study: overnight prior to dosing
- Housing: Macrolone cages type 3 (2-3 per cage)
- Diet: Altromin 1314, Altromin GmbH, 0-32791 Lage, Lippe ad libitum
- Water: domestic quality drinking water acidified with hydrochloric acid to pH 2.5 in order to prevent microbial growth
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C ± 3°C
- Humidity (%): 30 - 70 %
- Air changes (per hr): air changes 10 times/ hour
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours darkness - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- Sighting study: 1 female
main study: 4 females - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Each rat was observed 30 min., 2, 4 and 6 hours after the administration and thereafter daily. Body weight was recorded on days 0, 7 and 14.
- Necropsy of survivors performed: yes; all rats were killed by inhalation of CO2 on day 14 and subjected to a gross necropsy examination.
- Other examinations performed: clinical signs, body weight - Preliminary study:
- The animal included in the sighting study survived the treatment and showed slight signs of toxicosis, piloerection was observed 30 minutes, 2, 4 and 6 hours after the application of the test item. The post mortem inspection revealed no pathological abnormalities.
- Key result
- Sex:
- female
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- None of the female rats died.
- Clinical signs:
- They did not show marked signs of toxicosis. Piloerection was observed 30 minutes and 2 hours after the application of the test item, whereas normal behaviour was observed after 4 and 6 hours. From day 1 to the end of the observation period on day 14 no abnormalities were revealed.
- Body weight:
- The rats had a normal body weight gain during the study period.
- Gross pathology:
- The gross necropsy of the animals revealed no pathological abnormalities.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The oral LD50 females was determined to be > 2000 mg/kg bw.
- Executive summary:
The acute oral toxicity in rats was determined according to the method recommended in the OECD Guideline No. 420, "Acute Oral Toxicity - Fixed Dose Procedure", December 2001, and the commission directive 2004/73/EC "B.1 bis Acute Oral Toxicity: Fixed Dose Procedure", April 2004. The study was initiated with a sighting study, in which one female rat was given SILASTOL H 200 in a 2000 mg/kg bw dose. Slight signs of toxicosis (piloerection) were observed in this rat. Based on the results from the sighting study, the main study was carried out with four more female animals each given a dose of 2000 mg/kg bw. All animals in the main study survived the treatment, weight gain was normal and apart from piloerection no other clinical signs were observed. The gross necropsy of the animals revealed no pathological abnormalities. The oral LD50 (females) was determined to be > 2000 mg/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- Sept 1974
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Equivalent to OECD401; performed before GLP.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- only one sex tested, limitations in study reporting
- GLP compliance:
- no
- Remarks:
- performed before GLP guidelines
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: Hoe WISKf(SPF71)
- Source: Hoechst AG Kastengrund - SPF breed
- Weight at study initiation: 90-112 g (female); (mean = 100 g; n = 60)
- Age at study initiation: no data
- Fasting period before study: 16 hours before and 2 hours after application
- Diet: Altromin 1324 (Altromin GmbH, Lage/Lippe), ad libitum
- Water: Tap water ad libitum
- Acclimatization period: no data
ENVIRONMENTAL CONDITIONS
- Housing: in groups, in plastic cages, softwood pellets - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- - concentration in vehicle: 25 % (w/v)
- Doses:
- 6300 mg/kg
8000 mg/kg
9000 mg/kg
10000 mg/kg
12500 mg/kg
15000 mg/kg - No. of animals per sex per dose:
- 10 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Clinical observations after application / Weighing once weekly
- Necropsy of survivors performed: yes - Statistics:
- Probit analysis (method by Linder and Weber);
Confidence limits according to Cavalli-Sforza - Preliminary study:
- Preliminary experiments did not show differences related to gender. Therefore only females used for main study.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 10 490 mg/kg bw
- 95% CL:
- > 9 833 - <= 11 191
- Mortality:
- Sex: female, Dose: 6300 mg/kg bw, Mortality rate: 0 / 10
Sex: female, Dose: 8000 mg/kg bw, Mortality rate: 0 / 10
Sex: female, Dose: 9000 mg/kg bw, Mortality rate: 0 / 10
Sex: female, Dose: 10000 mg/kg bw, Mortality rate: 5 / 10
Sex: female, Dose: 12500 mg/kg bw, Mortality rate: 9 / 10
Sex: female, Dose: 15000 mg/kg bw, Mortality rate: 10 / 10 - Clinical signs:
- Mortally poisened animals died within 1-2 days after application.
Following symptoms were observed: disturbance of equilibrium, spasm.
The test substance was vomitted. - Body weight:
- - normal body weight gain in all surviving animals.
- Gross pathology:
- Dissection of rats killed at the end of the observation period revealed no macroscopic findings.
Necropsy of the deceased animals revealed following macroscopic findings: Stomach and oesophagus were filled with white foam. - Interpretation of results:
- not classified
- Conclusions:
- The median lethal dose of the test item (LD50) was 10490 mg per kg body weight. Based on the result of this study the test item is not subject for labelling and classification requirements according to regulatory requirements.
- Executive summary:
Based on results of the study conducted equivalent to OECD Guideline No 401 in rats, the median lethal dose of the test item was 10490 mg per kg body weight.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- GLP and Guideline conform studies
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Oral:
No data on the substance itself is available. The test substance is a mixture of C12 and C18 chain phosphoric acid esters. Therefore, read-across approach to the C12 and C18 phosphoric acid esters separately was applied.
Two read across studies are available assessing the acute oral toxicity of CAS 39322-78-6 and CAS 68987-29-1, respectively. These studies were used in a weight of evidence-approach.
Based on results of a study conducted equivalent to OECD Guideline No 401 in rats, the median lethal dose of the read across item (CAS 39322-78-6) was 10490 mg per kg body weight in rats.
Furthermore, the acute oral toxicity of the second read across substance (CAS 68987-29-1) in rats was determined according to the method recommended in the OECD Guideline No. 420, "Acute Oral Toxicity - Fixed Dose Procedure", December 2001, and the commission directive 2004/73/EC "B.1, Acute Oral Toxicity: Fixed Dose Procedure", April 2004. The study was initiated with a sighting study, in which one female rat was given the read across-substance in a 2000 mg/kg bw dose. Slight signs of toxicosis (piloerection) were observed in this rat. Based on the results from the sighting study, the main study was carried out with four more female animals each given a dose of 2000 mg/kg bw. All animals in the main study survived the treatment, weight gain was normal and apart from piloerection no other clinical signs were observed. The gross necropsy of the animals revealed no pathological abnormalities. The oral LD50 females was determined to be > 2000 mg/kg bw.
Therefore, as an overall conclusion, the acute oral toxicity of the test substance was considered to be >2000 mg/kg bw.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. Based on this data, the substance is considered not to be classified for acute toxicity under Regulation (EC) No 1272/2008, as amended for the tenth time in Regulation (EC) No 2017/776.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
